Literature DB >> 18571465

Testing human sera for antibodies against avian influenza viruses: horse RBC hemagglutination inhibition vs. microneutralization assays.

Ghazi Kayali1, Sharon F Setterquist, Ana W Capuano, Kendall P Myers, James S Gill, Gregory C Gray.   

Abstract

BACKGROUND: The hemagglutination inhibition (HI) assay is a frequently used method to screen human sera for antibodies against influenza A viruses. Because HI has relatively poor sensitivity in detecting antibodies against avian influenza A strains, a more complicated microneutralization (MN) assay is often preferred. Recent research suggests that the sensitivity of the HI assay can be improved by switching from the traditionally used turkey, guinea pig, human, or chicken RBCs to horse RBCs.
OBJECTIVE: To evaluate the performance of the horse RBC HI when screening for human antibodies against avian influenza types H3, H4, H5, H6, H7, H9, H11, and H12. STUDY
DESIGN: We evaluated the reproducibility of horse RBC HI and its agreement with MN results using sera from people exposed or not exposed to wild and domestic birds.
RESULTS: The horse RBC HI assay had high reliability (90%-100%) and good agreement with MN assay results (52%-100%).
CONCLUSION: The horse RBC HI assay is reliable, less expensive, less complex, and faster than the MN assay. While MN will likely remain the gold standard serologic assay for avian viruses, the horse RBC HI assay may be very useful as a screening assay in large-scale epidemiologic studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18571465      PMCID: PMC2574547          DOI: 10.1016/j.jcv.2008.04.013

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  16 in total

1.  Influenza A (H5N1): will it be the next pandemic influenza? Are we ready?

Authors:  John G Bartlett; Frederick G Hayden
Journal:  Ann Intern Med       Date:  2005-09-20       Impact factor: 25.391

2.  Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

Authors:  John J Treanor; James D Campbell; Kenneth M Zangwill; Thomas Rowe; Mark Wolff
Journal:  N Engl J Med       Date:  2006-03-30       Impact factor: 91.245

3.  Avian influenza. Combating the bird flu menace, down on the farm.

Authors:  Richard Stone
Journal:  Science       Date:  2006-02-17       Impact factor: 47.728

4.  Measurement of antibodies to avian influenza virus A(H7N7) in humans by hemagglutination inhibition test.

Authors:  Adam Meijer; Arnold Bosman; Esther E H M van de Kamp; Berry Wilbrink; Mirna Du Ry van Beest Holle; Marion Koopmans
Journal:  J Virol Methods       Date:  2005-11-03       Impact factor: 2.014

5.  Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003.

Authors:  Simona Puzelli; Livia Di Trani; Concetta Fabiani; Laura Campitelli; Maria Alessandra De Marco; Ilaria Capua; Jean Francois Aguilera; Maria Zambon; Isabella Donatelli
Journal:  J Infect Dis       Date:  2005-09-12       Impact factor: 5.226

Review 6.  Avian influenza--a pandemic waiting to happen?

Authors:  Jang Pin Liu
Journal:  J Microbiol Immunol Infect       Date:  2006-02       Impact factor: 4.399

7.  Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin.

Authors:  I Stephenson; J M Wood; K G Nicholson; M C Zambon
Journal:  J Med Virol       Date:  2003-07       Impact factor: 2.327

8.  Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine.

Authors:  I Stephenson; J M Wood; K G Nicholson; A Charlett; M C Zambon
Journal:  Virus Res       Date:  2004-07       Impact factor: 3.303

9.  Avian influenza among waterfowl hunters and wildlife professionals.

Authors:  James S Gill; Richard Webby; Mary J R Gilchrist; Gregory C Gray
Journal:  Emerg Infect Dis       Date:  2006-08       Impact factor: 6.883

Review 10.  Avian influenza virus infections in humans.

Authors:  Samson S Y Wong; Kwok-Yung Yuen
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

View more
  39 in total

1.  Avian influenza virus risk assessment in falconry.

Authors:  Andrea Kohls; Hafez Mohamed Hafez; Timm Harder; Andreas Jansen; Peter Lierz; Dörte Lüschow; Brunhilde Schweiger; Michael Lierz
Journal:  Virol J       Date:  2011-04-23       Impact factor: 4.099

2.  Detection of antibodies against Avian influenza virus subtypes H7 and H9 among veterinarians in Guangdong province, China.

Authors:  Shuo Su; Jidang Chen; Zhenpeng Cao; Alexander Lai; Honglang Gu; Changwen Ke; Jie Wu; Yugu Li; Wenbao Qi; Guihong Zhang
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

3.  Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads.

Authors:  Dace V Madore; Bruce D Meade; Fran Rubin; Carolyn Deal; Freyja Lynn
Journal:  Vaccine       Date:  2010-05-12       Impact factor: 3.641

4.  Evidence for H5 avian influenza infection in Zhejiang province, China, 2010-2012: a cross-sectional study.

Authors:  Lian-Hong Li; Zhao Yu; Wen-Sen Chen; She-Lan Liu; Ye Lu; Yan-Jun Zhang; En-Fu Chen; Jun-Fen Lin
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

5.  Seroprevalence survey of avian influenza A(H5N1) among live poultry market workers in northern Viet Nam, 2011.

Authors:  Tham Chi Dung; Pham Ngoc Dinh; Vu Sinh Nam; Luong Minh Tan; Nguyen Le Khanh Hang; Le Thi Thanh; Le Quynh Mai
Journal:  Western Pac Surveill Response J       Date:  2014-11-18

6.  Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets.

Authors:  R Colby Layton; Nikolai Petrovsky; Andrew P Gigliotti; Zemmie Pollock; Jennifer Knight; Nathaniel Donart; John Pyles; Kevin S Harrod; Peng Gao; Frederick Koster
Journal:  Vaccine       Date:  2011-07-06       Impact factor: 3.641

7.  Evidence for subclinical avian influenza virus infections among rural Thai villagers.

Authors:  Benjawan P Khuntirat; In-Kyu Yoon; Patrick J Blair; Whitney S Krueger; Malinee Chittaganpitch; Shannon D Putnam; Krongkaew Supawat; Robert V Gibbons; Sirima Pattamadilok; Pathom Sawanpanyalert; Gary L Heil; John A Friary; Ana W Capuano; Gregory C Gray
Journal:  Clin Infect Dis       Date:  2011-10       Impact factor: 9.079

8.  A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia.

Authors:  Ryuta Uraki; Zhenyu Piao; Yukihiro Akeda; Kiyoko Iwatsuki-Horimoto; Maki Kiso; Makoto Ozawa; Kazunori Oishi; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2015-06-29       Impact factor: 5.226

9.  Reproducibility of serologic assays for influenza virus A (H5N1).

Authors:  Iain Stephenson; Alan Heath; Diane Major; Robert W Newman; Katja Hoschler; Wang Junzi; Jacqueline M Katz; Jerry P Weir; Maria C Zambon; John M Wood
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

10.  Neutralizing DNA aptamers against swine influenza H3N2 viruses.

Authors:  Manoosak Wongphatcharachai; Ping Wang; Shinichiro Enomoto; Richard J Webby; Marie R Gramer; Alongkorn Amonsin; Srinand Sreevatsan
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.